Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study

Corticosteroid is commonly used to reduce damage from inflammatory reactions in coronavirus disease 2019 (COVID-19). We aim to determine the outcomes of corticosteroid use in critically ill COVID-19 patients. Ninety six critically ill patients, hospitalized in 14 hospitals outside Wuhan from January...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yichen, Li, Jie, Ke, Jia, Jiao, Na, Zhu, Lixin, Shen, Lihan, Chen, Lei, Jiang, Zhiqiang, Cheng, Sijing, Huang, Yibo, Zou, Yifeng, Zhu, Ruixin, Yan, Guangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900536/
https://www.ncbi.nlm.nih.gov/pubmed/33634148
http://dx.doi.org/10.3389/fmed.2021.604263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900536/
https://www.ncbi.nlm.nih.gov/pubmed/33634148
http://dx.doi.org/10.3389/fmed.2021.604263

Ejemplares similares